Unnamed company (Boston College)
Michael J. Naughton, professor
[email protected]
“This is a retinal implant technology that could dramatically improve vision in patients suffering from incurable retinal diseases such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD).”
Cadrus Therapeutics (UMass Medical School)
David Easson, president
[email protected]
“Cadrus Therapeutics, Inc is developing an innovative, receptor mediated, drug delivery technology to enable oral delivery of many of today’s injectable-drug products.”
gRadiant Research
Kathleen McMillan, president
[email protected]
“gRadient is developing a device for precisely controlled thermal therapy as a safer, less costly, and painless alternative to tonsillectomy in children and adults.”
Immuneering Corporation (MIT/Harvard University)
Benjamin Zeskind, founder and CEO
[email protected]
“Immuneering is developing groundbreaking patient stratification technology to pre-identify patients who will respond to specific therapies.”
Lumos Catheter Systems (Children’s Hospital Boston)
Farhad Imam, president, CMO
[email protected]
“Lumos Catheter Systems has developed a simple solution to enable real-time visualization of invasive catheters…during insertion procedures to reduce the risk of misplacements.”
Unnamed company (McClean Hospital)
Miles Cunningham, laboratory director
[email protected]
Technology 1: “The Intracerebral Microinjection Instrument (IMI) is the only neurosurgical device that has a minimized delivery cannula diameter and allows dissemination of medicine from a single proximal brain penetration…”
Technology 2: “Convection Enhanced Delivery (CED) is the continuous injection into the brain under positive pressure of a fluid therapeutic.”
Moma Therapeutics
Daniel Katzman, CEO
[email protected]
“Moma develops therapies for regenerative medicine employing injectable gel-based scaffolds designed to reprogram the function of cells in vivo and promote tissue regeneration.”
Orbital Therapy
Jason Koshnitsky, CEO
[email protected]
” Orbital Therapy…is developing a dedicated self-shielded radiation therapy device for the treatment of breast cancer.”
Robopsy (MGH/MIT)
Rajiv Gupta, MGH laboratory director
[email protected]
“Our mission is to devlop a suite of image-guided, patient-friendly electromechanical tools that allows for more accurate diagnosis and treatment of disease.”
Unnamed company (UMass Medical School)
Alexander B. Sigalov, research assistant professor
[email protected]
“Our technology, which is based on our novel model of immune signaling…prevents communication via the cell membrane between the receptor and its associated signaling proteins…thereby enabling small molecules and doses.”
